ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 5,330.00
-20.00 (-0.37%)
At close: Aug 4, 2025, 3:30 PM KST
ImmuneOncia Therapeutics Revenue
In the year 2024, ImmuneOncia Therapeutics had annual revenue of 654.54M KRW with 495.04% growth.
Revenue
654.54M
Revenue Growth
+495.04%
P/S Ratio
601.83
Revenue / Employee
n/a
Employees
n/a
Market Cap
393.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 654.54M | 544.54M | 495.04% |
| Dec 31, 2023 | 110.00M | -7.62B | -98.58% |
| Dec 31, 2022 | 7.73B | 7.70B | 21,413.30% |
| Dec 31, 2021 | 35.95M | 33.45M | 1,337.90% |
| Dec 31, 2020 | 2.50M | 1.00M | 66.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hanwha Aerospace | 15.28T |
| Hyundai Motor Company | 178.98T |
| HD Hyundai Heavy Industries | 15.32T |
| Doosan Enerbility | 15.88T |